Evidence map›Paper›PMID 29663036›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2018

Systemic administration of heparin ameliorates radiation-induced oral mucositis-preclinical studies in mice.

Maria Kowaliuk, Eva Bozsaky, Sylvia Gruber, Peter Kuess, Wolfgang Dörr

Open access · hybridAbstract read
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Heparin treatment mitigates radiation-induced oral mucositis in mice by interplaying with repopulation processes.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria KowaliukDepartment of Radiotherapy-ATRAB-Applied and Translational Radiobiology and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Waehringer Gürtel 18-20, 1090, Vienna, Austria. maria.kowaliuk@meduniwien.ac.at.ORCID http://orcid.org/0000-0001-7825-9459
Eva BozsakyDepartment of Radiotherapy-ATRAB-Applied and Translational Radiobiology and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Waehringer Gürtel 18-20, 1090, Vienna, Austria.
Sylvia GruberDepartment of Radiotherapy-ATRAB-Applied and Translational Radiobiology and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Waehringer Gürtel 18-20, 1090, Vienna, Austria.
Peter KuessDepartment of Radiotherapy-Christian Doppler Laboratory for Medical Radiation Physics for Radiation Oncology, Medical University of Vienna, Vienna, Austria.
Wolfgang DörrDepartment of Radiotherapy-ATRAB-Applied and Translational Radiobiology and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Waehringer Gürtel 18-20, 1090, Vienna, Austria.
Medical University of Vienna · ATChristian Doppler Laboratory for Thermoelectricity · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe present study investigates the impact of systemic application of heparins on the manifestation of radiation-induced oral mucositis in a well-established mouse model. MATERIALS AND

methodsMale C3H/Neu mice were irradiated with either single-dose or fractionated irradiation protocols with 5 × 3 Gy/week, given over one (days 0-4) or two (days 0-4, 7-11) weeks. All fractionation protocols were concluded by a local test irradiation (day 7/14) using graded doses to generate complete dose-effect curves. Daily doses of unfractionated or low molecular weight heparin (40 or 200 I.U./mouse, respectively) were applied subcutaneously over varying time intervals. The incidence and the time course of mucosal ulceration, corresponding to confluent mucositis in patients (RTOG/EORTC grade 3), were analysed as clinically relevant endpoints.

resultsSystemic application of heparins significantly increased the iso-effective doses for the induction of mucosal ulceration, particularly in combination with fractionated irradiation protocols. Moreover, a tentative prolongation of the latent time and a pronounced reduction of the ulcer duration were observed.

conclusionThese data provide the first evidence for a protective and/or mitigative effect of heparins for radiation-induced oral mucositis. Further studies are ongoing investigating the underlying mechanism.

Indexed as

Disease Models, AnimalAnimalsEnoxaparinHeparinHumansInjections, SubcutaneousMiceMice, Inbred C3HRadiation InjuriesStomatitisEnoxaparinHeparinHeparinMouseNormal tissue effectsOral mucositisRadiotherapy

Identifiers

PMID29663036
PMCPMC6008356
OpenAlexW2802256643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.